These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25376752)

  • 1. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
    Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo.
    Le Poole IC; Mehrotra S
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S38-S45. PubMed ID: 28941492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients.
    Giri PS; Dwivedi M; Laddha NC; Begum R; Bharti AH
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):566-578. PubMed ID: 31917889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
    Giri PS; Mistry J; Dwivedi M
    J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS; Patel S; Begum R; Dwivedi M
    Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
    Abdallah M; Lotfi R; Othman W; Galal R
    Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
    Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
    Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
    Giri PS; Bharti AH; Begum R; Dwivedi M
    Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.
    Dwivedi M; Laddha NC; Arora P; Marfatia YS; Begum R
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):586-91. PubMed ID: 23574980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
    Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses.
    Terras S; Gambichler T; Moritz RK; Altmeyer P; Lambert J
    Int J Dermatol; 2014 Mar; 53(3):294-9. PubMed ID: 23968190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T-cell cytokines in patients with nonsegmental vitiligo.
    Kidir M; Karabulut AA; Ercin ME; Atasoy P
    Int J Dermatol; 2017 May; 56(5):581-588. PubMed ID: 28247923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.
    Lee HY; Hong YK; Yun HJ; Kim YM; Kim JR; Yoo WH
    Rheumatology (Oxford); 2008 Jun; 47(6):789-94. PubMed ID: 18388146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced skin homing by functional Treg in vitiligo.
    Klarquist J; Denman CJ; Hernandez C; Wainwright DA; Strickland FM; Overbeck A; Mehrotra S; Nishimura MI; Le Poole IC
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):276-86. PubMed ID: 20175879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
    Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
    J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.